Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
monoclonal antibodies
Biotech
Regeneron ends eye disease trial following safety review
The Titan study tested REGN7041, an anti-CD3 monoclonal antibody, in patients with inflammation of the uvea, the eye’s middle layer.
Darren Incorvaia
Aug 17, 2026 2:30pm
US taps small biotech for experimental Ebola treatment
May 20, 2026 7:18pm
New antibodies stop measles from stabbing cells, study finds
May 7, 2026 11:00am
New biotech Slate aims to solve migraine injection equation
Feb 24, 2026 7:30am
ARPA-H director eyes future beyond vaccines
Jan 20, 2026 5:00am
Sanofi signs 2nd biotech deal of the day
Dec 15, 2025 5:50pm
